Literature DB >> 21864936

Escherichia coli bacteraemia: how preventable is it?

J Underwood1, J L Klein, W Newsholme.   

Abstract

Mandatory bacteraemia reporting was extended to include Escherichia coli from June 2011. The purpose of this study was to investigate whether the success seen in reducing meticillin-resistant Staphylococcus aureus infection rates could be duplicated with E. coli. All cases of E. coli bacteraemia occurring at our Trust in 2010 were reviewed. There were 216 episodes of E. coli bacteraemia, of which 63% were community-acquired. Only 19% had a potentially preventable cause identified, the majority (71%) of whom had urinary catheter-associated bacteraemia. These data must be kept in mind should targets to reduce E. coli bacteraemia be set in the future.
Copyright © 2011 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21864936     DOI: 10.1016/j.jhin.2011.07.005

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  2 in total

1.  The effect of antimicrobial photodynamic therapy with radachlorin® on Staphylococcus aureus and Escherichia coli: an in vitro study.

Authors:  Reza Fekrazad; Hadi Zare; Sara Mohammadi Sepahvand; Parisa Morsali
Journal:  J Lasers Med Sci       Date:  2014

2.  Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study.

Authors:  Manas Kanoksil; Anchalee Jatapai; Sharon J Peacock; Direk Limmathurotsakul
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.